Miscellanous

Steadyfutal
  • Active Substance (s) : Betahistine dihydrochloride 6 mg, 16 mg and 24 mg
  • Dosage Form : Tablets
  • Pack : 10 tablets/strip
  • Indication :
    • Vertigo
    • Tinnitus
    • Hearing loss associated with Ménière's syndrome
  • Product Description : Steadyfutal acts both as partial histamine H1 receptor agonist and histamine H3-receptor antagonist also in neuronal tissue, and has negligible H2-receptor activity. Steadyfutal increases histamine turnover and release by blocking presynaptic H3-receptors and inducing H3-receptor down-regulation
  • Recommended Daily Dosage :
    • Initially 48 mg/day taken in divided doses and preferably with meals
    • Maintenance doses are generally in the range 24-48 mg daily